Most Read News


Pharma industry gets disturbed at beginning of the year for both rebate and drug price

Pharmaceutical companies seem disturbed by the search and seizure on two pharmaceutical companies at the beginning of the year. It was told, first of all, the search on these two companies are not about rebates, but ...

Bayer’s careless attitude over Aspirin recall angers pharmacies

Over the recovery of Bayer Aspirin, the pharmacy circles have made complaints over the attitude of the manufacturer Bayer and the previous seller Dong-A Pharm(agreement expired) for pushing jobs on each other. Accord...

Ildong Pharmaceutical challenges to KRW 100 billion market of filler

Ildong Pharmaceutical(CEO Woong-Sup Yoon) released ‘Neobelle,’ hyaluronic acid filler for wrinkle improvement, and has started to pioneer its market. Based on the original techn...

What are most common violations made by MSDF employees?

According to an overall inspection for its employees about the public servants’ code of conduct, made by the Ministry of Health and Welfare(MFDS), the most common violations were violation of prior notice for outside ...

Hanmi-MSD’s export agreement of ‘Rosuzet,’ hyperlipidemia combination drug, to 23 countries

Hanmi-developed ‘Rosuzet’ will be exported to 23 foreign countries via MSD. It was announced on the 4th Hanmi Pharm and MSD has recently signed a license agreement of exporting Rosuzet and decided to export three dif...

Hanmi Pharm signs modified agreement of long-acting antidiabetic with Sanofi

Hanmi Pharm(CEO Kwan-Soon Lee) announced on the 29th that it signed a partial modification of the license agreement made on November 2015 for ‘Quantum Project,’ a long-acting antidiabetic portfolio, with Sanofi. Acco...

Pharmacy distribution ‘careful and careful’ on large pharmacies nearby or in hospital

The pharmaceutical distribution industry has raised a concern on some companies’ excessive actions to expand the number of their clients. In the industry, a number of managers had to take responsible for frequent ban...

Be alerted on selling shortage-prevented drugs less than 91% of the upper limit price

Pharmaceutical manufacturers and importers were alerted because they will get charged if selling shortage-prevented drugs for less than 91% of their upper limit price from the January 1 2017. The Korea Pharmaceutical...

Sleep endoscopy will be covered by National Health Insurance

The Ministry of Health and Welfare held the 19th National Health Insurance Policy Deliberation Committee(hereinafter referring to NHIPDC, Chairman: Vice Minister Moon-Gyu Bang) on the 20th, made a decision to extend t...

Hanmi Flu outnumbers Tamiflu in flu medicine market

The market share of ‘Hanmi Flu,’ a Korean influenza treatment, exceeded 50%. According to Hanmi Pharm on the 21st, after the flu watch was alerted, its prescriptions were rapidly increased, which made the market shar...

Civic organizations turned in written opinion to justice department for IMS Health’s health information trading

3 civic organizations, including the Civic Interests Center of Citizens’ Coalition for Economic Justice, turned in a written opinion to the criminal department taking in charge of the IMS Health’s health information t...

MFDS’s largest number of voluntary resignations, expecting to resolve personnel congestion

Since the highest number of voluntary resignations were made at the Ministry of Food and Drug Safety(MFDS), its issue with personnel congestion is going to be partially addressed. According to the MFDS, there were 23...

Alteogen completes clinical trial of ‘Herceptin’ biosimilar

Alteogen announced the Phase 1 clinical trial of a biosimilar of Herceptin, a breast cancer therapy, which has been conducted in Canada since February, was successfully completed. Alteogen has carried out the Phase 1...

Drug distribution industry’s ‘new question’ to solve over MSD’s margin cut

The pharmaceutical distribution industry will have to take a new test over the MSD Korea’s plan to cut distribution margins. Depending on how the industry will solve the issue, it will become a chance for pharmaceutic...

Yuhan establishes foundation to keep top sales position in pharma industry

Since Yuhan Corporation and Boehringer Ingelheim were agreed to renew their strategic partnership, it was anticipated Yuhan Corporation will keep its top sales position in the industry for a while. Yuhan Corporation ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.